Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Formation and Antitumor Activity of PNU-159682, A Major Metabolite of Nemorubicin in Human Liver Microsomes
- L. Quintieri, C. Geroni, +5 authors M. Floreani
- Biology, Medicine
- Clinical Cancer Research
- 15 February 2005
Purpose: Nemorubicin (3′-deamino-3′-[2″(S)-methoxy-4″-morpholinyl]doxorubicin; MMDX) is an investigational drug currently in phase II/III clinical testing in hepatocellular carcinoma. A bioactivation… Expand
Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties.
- M. Fantin, L. Quintieri, +6 authors C. Vizler
- Biology, Medicine
- European journal of pharmacology
- 27 March 2006
Previous investigations indicate that some of the metabolites of the hemorheological agent pentoxifylline (PTX), namely 1-(5-hydroxyhexyl)-3,7-dimethylxanthine (M1),… Expand
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.
- L. Quintieri, M. Fantin, +5 authors M. Floreani
- Biology, Medicine
- Biochemical pharmacology
- 15 September 2008
We recently demonstrated that nemorubicin (MMDX), an investigational antitumor drug, is converted to an active metabolite, PNU-159682, by human liver cytochrome P450 (CYP) 3A4. The objectives of this… Expand
Lower Troncoso Eolian Bodies Identification in the Neuquen Basin, Argentina: A Different Approach and some Geological Implications
- D. Dajczgewand, A. Nocioni, M. Fantin, S. Minniti, R. Calegari, A. Gavarrino
- Geography
- 2006
Lower Troncoso Member is one of the most important reservoirs within the Neuquen Basin, Argentina, where it hosts large amounts of reserves.
INVOLVEMENT OF MURINE CYTOCHROME P450 3A ENZYMES IN THE BIOACTIVATION OF METHOXYMORPHOLINYL DOXORUBICIN (NEMORUBICIN)
- M. Fantin, P. Fávero, M. Caruso, R. Battaglia, M. Floreani
- Biology
- 2003
Background: Methoxymorpholinyl doxorubicin (nemorubicin; MMDX), a doxorubicin (DX) derivative bearing a methoxymorpholinyl group at position 3’ of the sugar moiety, is currently under clinical… Expand